跳至主要内容
临床试验/NCT02632851
NCT02632851已完成不适用

Non-interventional Multicentric Study on Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

Bitop AG1 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bitop AG
入组人数
135
试验地点
1
主要终点
Change in Bronchitis Severity Score on physician´s evaluation (5 point IMOS scale)

研究概览

简要总结

This observational, non-interventional multicentric study compares the inhalation therapy on patients suffering on respiratory tract infections and/or acute bronchitis between Ectoin inhalation solution and Pari NaCl (0.9%) inhalation solution

详细描述

The assessment focuses on the bronchitis Severity Score (BSS) for standardized use in clinical studies with the outcome criteria of cough, sputum production, rales/rhonchi, chest pain during coughing and dysnoea

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • according to instruction for use

排除标准

  • according to instruction for use

结局指标

主要结局

Change in Bronchitis Severity Score on physician´s evaluation (5 point IMOS scale)

时间窗: day 7

Assessment of bronchits severity score on a 5 point IMOS scale (complete recovery, major improvement, slight to moderate improvement, no change, deterioration) of symptoms: Cough, sputum production, rales/rhonchi, chest pain during coughing, dyspnoea

次要结局

  • Change in bronchitis symptoms evaluated on patients´ diaries (5 point scale)(day 14)
  • patients´ evaluation of tolerability (4 point scale)(day7)
  • physicians´ evaluation of tolerability (4 point scale)(day 7)
  • patients´ evaluation of efficacy (five point IMOS scale)(day 7)
  • physicians´ evaluation of efficacy (five point IMOS scale)(day 7)
  • Change in number and type of adverse events(day 7)

研究者

发起方
Bitop AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验